ALNY stock news
This page provides real-time market news, earnings updates, and company announcements related to Alnylam Pharmaceuticals, Inc. (ALNY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-23 21:52 EST
Walmart Set to Enter Nasdaq 100 on January 20, Replacing AstraZeneca
101 finance2026-01-10 12:54:14
Stocks Rebound as Semiconductor and Data Storage Firms Surge
101 finance2026-01-13 00:45:22
On the premier platform for biotechnology, revived enthusiasm faces a critical examination
101 finance2026-01-16 11:51:07
Alnylam: Fourth Quarter Financial Highlights
101 finance2026-02-12 13:27:32
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
Finviz2026-02-13 16:21:42
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Finviz2026-02-14 06:24:02
The S&P 500 index closed roughly flat in early trading, with real estate and financial sectors up 1%, technology up 0.4%, and materials, energy, and consumer staples sectors down as much as 1.6%.
华尔街见闻2026-02-17 21:02:20
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
Finviz2026-02-18 13:33:35
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge
Finviz2026-02-20 09:09:41
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
Finviz2026-03-05 13:33:09
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Finviz2026-03-05 18:39:49
Alnylam Shares Drop 2.07% Even After $1.13B Cardio Collaboration, Trading Volume Places at 363rd
101 finance2026-03-06 00:15:38
Alnylam's $1.23B Tenaya Pact Drives Modest Gain as Stock Ranks 426th in $320M Volume
101 finance2026-03-07 00:30:49
Alnylam Rebounds with 0.91 Increase; Trading Volume Places 422nd Following EPS Outperformance and Analyst Rating Boosts
101 finance2026-03-10 00:42:34
BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz
Finviz2026-03-10 19:06:55
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-11 20:09:56
Alnylam's Stock Slumps 0.6% on Q4 Revenue Miss Despite 81% Full-Year Growth and 23% Volume Decline
101 finance2026-03-12 00:33:47
Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.
老虎证券2026-03-16 08:10:00
Qualcomm, Adobe cut: Leading Wall Street analysts weigh in
101 finance2026-03-16 13:45:49
Alnylam Stock Jumps 1.75% After Outperforming Earnings Expectations and Positive Analyst Outlook, Even as Revenue Falls Short; Trading Volume Reaches $400M, Placing 296th in Market Turnover
101 finance2026-03-17 00:03:41
Can Alnylam's Pipeline Medications Drive Sustainable Growth in the Future?
101 finance2026-03-19 15:40:25
Alnylam's Modest 0.34% Rally Driven by 211.89% Volume Spike, Ranking 359th as Mixed Earnings and Pipeline Progress Attract Investors
101 finance2026-03-21 00:27:47
Aera Therapeutics’ Delivery Breakthrough Could Reshape Genetic Medicine—Watch Mid-2026 Catalyst
101 finance2026-03-22 00:18:39
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
Finviz2026-02-13 16:21:42
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Finviz2026-02-14 06:24:02
The S&P 500 index closed roughly flat in early trading, with real estate and financial sectors up 1%, technology up 0.4%, and materials, energy, and consumer staples sectors down as much as 1.6%.
华尔街见闻2026-02-17 21:02:20
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
Finviz2026-02-18 13:33:35
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge
Finviz2026-02-20 09:09:41
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
Finviz2026-03-05 13:33:09
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Finviz2026-03-05 18:39:49
Alnylam Shares Drop 2.07% Even After $1.13B Cardio Collaboration, Trading Volume Places at 363rd
101 finance2026-03-06 00:15:38
Alnylam's $1.23B Tenaya Pact Drives Modest Gain as Stock Ranks 426th in $320M Volume
101 finance2026-03-07 00:30:49
Alnylam Rebounds with 0.91 Increase; Trading Volume Places 422nd Following EPS Outperformance and Analyst Rating Boosts
101 finance2026-03-10 00:42:34
BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz
Finviz2026-03-10 19:06:55
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-11 20:09:56
Alnylam's Stock Slumps 0.6% on Q4 Revenue Miss Despite 81% Full-Year Growth and 23% Volume Decline
101 finance2026-03-12 00:33:47
Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.
老虎证券2026-03-16 08:10:00
Qualcomm, Adobe cut: Leading Wall Street analysts weigh in
101 finance2026-03-16 13:45:49
Alnylam Stock Jumps 1.75% After Outperforming Earnings Expectations and Positive Analyst Outlook, Even as Revenue Falls Short; Trading Volume Reaches $400M, Placing 296th in Market Turnover
101 finance2026-03-17 00:03:41
Can Alnylam's Pipeline Medications Drive Sustainable Growth in the Future?
101 finance2026-03-19 15:40:25
Alnylam's Modest 0.34% Rally Driven by 211.89% Volume Spike, Ranking 359th as Mixed Earnings and Pipeline Progress Attract Investors
101 finance2026-03-21 00:27:47
Aera Therapeutics’ Delivery Breakthrough Could Reshape Genetic Medicine—Watch Mid-2026 Catalyst
101 finance2026-03-22 00:18:39
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
ALNY stock chart
ALNY stock detailsALNY stock price change
On the last trading day, ALNY stock closed at 312.17 USD, with a price change of 0.34% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more